According to a market report by Lucintel, the future of the global opthalmic viscoelastic device (OVD) market looks promising with opportunities in the cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery applications. The global opthalmic viscoelastic device (OVD) market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 4.3% from 2024 to 2030. The major drivers for this market are growing prevalence of cataract and glaucoma and rising number of eye surgeries performed.
A more than 150-page report to understand trends, opportunity and forecast in opthalmic viscoelastic device (OVD) market to 2030 by product (cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic), application (cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery), end use (hospitals, ophthalmic clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that cohesive ophthalmic viscoelastic will remain the larger segment over the forecast period due to its various advantages, such as longer shelf life, better performance, and have variety of application.
Within this market, cataract surgery is expected to witness the highest growth over the forecast period.
Download sample by clicking on opthalmic viscoelastic device (OVD) market
APAC is expected to witness highest growth over the forecast period due to growing old age population, increasing patient interest in eye care, and presence of key players in the region.
Bausch Health, Eyekon Medical, Bohus Biotech, Carl Zeiss Meditec, Cima Technology are the major suppliers in the opthalmic viscoelastic device (OVD) market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Medical Grade Silicone Market
Rabies Vaccine Market
Respiratory Virus Vaccine Market
Typhoid Fever Vaccine Market
Acoustic Camera Market
Hybrid Device Market